Supraventricular Tachycardia

• FDA approval · 2017-06-08
  FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approves Sun Pharmaceutical's diltiazem hydrochloride as a generic product under an original ANDA.

• FDA approval · 2017-05-05
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Nivagen Pharmaceuticals, Inc.)

  The FDA approved the original application for verapamil hydrochloride from Nivagen Pharmaceuticals, Inc. as a generic product.

• FDA approval · 2017-01-23
  FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)

  The FDA approved a supplemental application for Cardizem CD (diltiazem hydrochloride) from Bausch Health US LLC under NDA 020062, allowing c…

• FDA approval · 2016-11-18
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)

  FDA approved a supplemental application for Verapamil hydrochloride from Teva Pharmaceuticals Inc.

• FDA approval · 2016-11-18
  FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)

  FDA approved Oceanside Pharmaceuticals' supplemental application for diltiazem hydrochloride. The approval confirms a modification to the pr…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2016-11-18
  FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)

  FDA approved a supplemental application for Cardizem CD (diltiazem hydrochloride) submitted by Bausch Health US LLC.

• FDA approval · 2016-05-29
  FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)

  The FDA approved a supplemental application for Propafenone hydrochloride from Strides Pharma Science Limited.

• FDA approval · 2016-04-07
  FDA Approved: ESMOLOL HYDROCHLORIDE IN WATER — Original Application (WG Critical Care, LLC)

  FDA approved Esmolol hydrochloride in water as a new drug product under NDA205703 (Original Application) from WG Critical Care, LLC.

• FDA approval · 2015-12-21
  FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)

  FDA approves a supplemental application for Inderal LA (propranolol hydrochloride) by ANI Pharmaceuticals, Inc., granting approval for chang…

• FDA approval · 2015-11-20
  FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)

  FDA approved a supplemental application for diltiazem hydrochloride extended-release from Oceanside Pharmaceuticals.

• FDA approval · 2015-10-14
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for Verapamil Hydrochloride (generic) from Chartwell RX, LLC.

• FDA approval · 2015-10-05
  FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for amiodarone hydrochloride submitted by Sun Pharmaceutical Industries, Inc.

• FDA approval · 2015-07-02
  FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Limited)

  FDA approved a supplemental application for amiodarone hydrochloride by Advagen Pharma Limited. This action confirms regulatory clearance fo…

• FDA approval · 2015-01-26
  FDA Approved: BREVIBLOC — Supplemental Application (Baxter Healthcare Corporation)

  The FDA approved a supplemental application for Brevibloc (esmolol hydrochloride) submitted by Baxter Healthcare Corporation.

• FDA approval · 2013-05-31
  FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for amiodarone hydrochloride submitted by Chartwell RX, LLC. This marks an approval of a supplement …

• FDA approval · 2012-11-26
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approves a supplemental application for verapamil hydrochloride from Actavis Pharma, Inc. for an already authorized product.

• FDA approval · 2011-11-14
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)

  FDA approved a supplemental application for Verapamil hydrochloride submitted by Teva Pharmaceuticals Inc. This action finalizes changes to …

• FDA approval · 2011-11-02
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)

  FDA approved a supplemental NDA for Verapamil Hydrochloride from Exela Pharma Sciences, LLC under NDA 018925.

• FDA approval · 2011-10-28
  FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)

  The FDA approved Actavis Pharma, Inc.'s supplemental application for CARTIA XT (diltiazem hydrochloride) under ANDA074752.

• FDA approval · 2011-08-03
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved verapamil hydrochloride as an original application generic drug by Glenmark; the product is indicated for conditions treated by…

• FDA approval · 2011-07-11
  FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)

  FDA approved a supplemental application for propafenone hydrochloride, enabling its generic marketing by Strides Pharma Science Limited as a…

• FDA approval · 2011-01-27
  FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for Diltiazem Hydrochloride from Teva Pharmaceuticals USA, Inc., updating the product's regulato…

• FDA approval · 2011-01-20
  FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application for diltiazem hydrochloride (Apotex Corp.), a generic calcium channel blocker. The approval covers t…

• FDA approval · 2011-01-13
  FDA Approved: ADENOSINE — Supplemental Application (Mylan Institutional LLC)

  FDA approved a supplemental application for adenosine from Mylan Institutional LLC.

• FDA approval · 2010-11-22
  FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)

  The FDA approved a supplemental NDA for Cardizem CD (diltiazem hydrochloride) submitted by Bausch Health US LLC.